Sanofi Biotechnology;Regeneron Pharmaceuticals, Inc.
发明人:
HUANG, Xiaohong,JASSON, Martine,MARKS, Vanessa,RADIN, Allen
申请号：
LT12769684
公开号：
LT2766039T
申请日:
2012.10.10
申请国别(地区):
LT
年份:
2018
代理人:
摘要：
The present invention provides compositions and methods of treating and improving the symptoms of rheumatoid arthritis using an antibody or antigen-binding fragment thereof that specifically binds human interleukin-6 receptor (hIL-6R) with a DMARD.
